Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

Rhea-AI Summary

Oracle has launched Oracle Analytics Intelligence for Life Sciences, an AI-powered cloud platform that unifies diverse data sets for streamlined insight generation in healthcare research. The platform integrates with existing Oracle Health and Life Sciences applications, featuring pre-built datasets, data pipelines, and analytics tools powered by Oracle Health Data Intelligence. Built on Oracle Cloud Infrastructure, it incorporates real-world data sources including CancerMPact and multiomics, enabling organizations to better identify market needs and optimize therapeutic strategies. The platform offers continuous updates through the Oracle Learning Health Network and integrates with various health data sources including EHRs, insurance claims, and demographic records.

Positive

• Launch of new AI-powered analytics platform expanding Oracle's healthcare solutions portfolio
• Integration with existing Oracle Health and Life Sciences applications enhancing product ecosystem
• Access to diverse real-world data sources including CancerMPact and multiomics
• Platform built on secure Oracle Cloud Infrastructure (OCI) ensuring robust performance

Negative

• None.

Insights

Tech Expert

Oracle's new Analytics Intelligence platform represents a significant advancement in healthcare data analytics. The integration of AI capabilities with real-world data sources and Oracle's extensive healthcare infrastructure creates a powerful ecosystem for life sciences research. The platform's ability to unify disparate datasets while leveraging Oracle Cloud Infrastructure's security and performance capabilities addresses a critical market need.

The platform's integration with the Oracle Learning Health Network and Real World Data creates a continuous learning loop that could provide a competitive advantage in the healthcare analytics market. This positions Oracle to capture a larger share of the growing healthcare analytics market, estimated at $45 billion globally. The EHR-agnostic approach and pre-built analytics capabilities lower the barrier to entry for potential clients, potentially accelerating adoption rates.

Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies

Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics

NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidisciplinary research questions, generate insights, and integrate that information back into their existing Oracle Health and Life Sciences applications. As a result, life sciences organizations can more accurately identify market needs, assess commercial viability, and optimize therapeutic launch strategies. This innovation is yet another step in Oracle's vision to bridge the gap between clinical research and clinical care.

"Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."

Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.

Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.

This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.

The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.

For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/

To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html

SOURCE Oracle

FAQ

What is Oracle Analytics Intelligence for Life Sciences and when was it launched?

Oracle Analytics Intelligence for Life Sciences is an AI-powered cloud analytics platform launched on October 30, 2024, designed to unify healthcare data sets and accelerate insight generation for life sciences organizations.

What data sources does Oracle (ORCL) Analytics Intelligence platform integrate?

The platform integrates data from electronic health records (EHR), enterprise applications, insurance claims, demographic records, CancerMPact, and multiomics sources, along with Oracle Real World Data (ORWD).

How does Oracle (ORCL) Analytics Intelligence benefit life sciences organizations?

It helps organizations identify market needs, assess commercial viability, optimize therapeutic launch strategies, and generate insights through a unified intelligent workbench with pre-built datasets and analytics tools.